OnCo
termsTerm

Metabolic syndrome and insulin resistance

aka Insulin resistance, Hyperinsulinaemia

Metabolic syndrome is a cluster of central obesity, high blood pressure, high blood sugar and abnormal blood fats. It raises the risk of several cancers and worsens outcomes after diagnosis, largely through high insulin levels.

Insulin and IGF-1 are mitogenic and anti-apoptotic through the PI3K-AKT-mTOR pathway; hyperinsulinaemia also lowers sex-hormone-binding globulin, raising free oestrogen and androgen. Metabolic syndrome is associated with higher incidence of colorectal, liver, pancreatic, endometrial and postmenopausal breast cancer, and with recurrence in colon and breast cancer survivors. Metformin, despite strong epidemiology, failed to improve breast cancer outcomes in the MA.32 randomised trial, a caution about observational metabolic signals.

Category
Nutrition & lifestyle

Connected

13top

Pages like this

not linked directly; found by shared links